InMed Pharmaceuticals Inc. is a biopharmaceutical company specializing in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The company is utilizing its proprietary Intelligent Cannabinoid Drug Design Platform "IDP" to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific diseases. Our extensive research and new intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Ocular, Cancer, Inflammation, Pain & Arthritis disease areas.
www.otcmarkets.com/stock/IMLFF/profile
**********************************************
Four Long Term Penny Stock Picks For A Profitable 2017
Jan. 12, 2017 2:55 PM ET
seekingalpha.com/instablog/...enny-stock-picks-profitable-2017
**********************************************
A Short Term Play With 100% Gain Potential
December 10th, 2016
www.otcmarkets.net/short-term-alert/...ith-100-gain-potential/
Updated Target 01/13/2017 : 0.40
www.otcmarkets.com/stock/IMLFF/profile
**********************************************
Four Long Term Penny Stock Picks For A Profitable 2017
Jan. 12, 2017 2:55 PM ET
seekingalpha.com/instablog/...enny-stock-picks-profitable-2017
**********************************************
A Short Term Play With 100% Gain Potential
December 10th, 2016
www.otcmarkets.net/short-term-alert/...ith-100-gain-potential/
Updated Target 01/13/2017 : 0.40